阿德福韦酯致低磷性骨软化症1例
发布时间：2018-10-20 19:37
【摘要】：正阿德福韦酯是一种核苷酸类抗乙型肝炎病毒(HBV)药物,对耐拉米夫定的HBV具有良好活性,其作用温和,应用广泛。长期服用阿德福韦酯可以导致低磷性骨软化症,临床医师往往对此认识不足,造成误诊误治。本文报道1例阿德福韦酯致低磷性骨软化症,总结该不良反应的特点,为临床安全用药提供参考。
[Abstract]:Orthoadefovir ester is a kind of nucleotide anti-HBV (HBV) drug, which has good activity against HBV of lamivudine, and its effect is mild and widely used. Long-term administration of adefovir can lead to low-phosphorous osteomalacia, which is often poorly understood by clinicians and misdiagnosed and mistreated. A case of low phosphorus osteomalacia induced by adefovir ester was reported.
【作者单位】： 郑州大学第一附属医院药剂科;
【分类号】：R512.62
本文编号：2284181
[Abstract]:Orthoadefovir ester is a kind of nucleotide anti-HBV (HBV) drug, which has good activity against HBV of lamivudine, and its effect is mild and widely used. Long-term administration of adefovir can lead to low-phosphorous osteomalacia, which is often poorly understood by clinicians and misdiagnosed and mistreated. A case of low phosphorus osteomalacia induced by adefovir ester was reported.
【作者单位】： 郑州大学第一附属医院药剂科;
【分类号】：R512.62
【相似文献】
相关期刊论文 前1条
1 袁乐媛;王柏芳;王炳元;韩慧芳;高君;唐芳馨;李雪华;;阿德福韦酯诱发范可尼综合征和骨软化症病例报告和误诊分析[J];传染病信息;2013年02期
，本文编号：2284181
本文链接：https://www.wllwen.com/yixuelunwen/xiaohjib/2284181.html
最近更新
教材专著
